Nicholas J. Talley

Newcastle University
Country flagAustralia

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

INTRODUCTION: Disorders of gut-brain interaction (DGBIs) may originate in childhood. There are currently limited data on persistence of DGBI into adulthood and risk factors for persistence. Furthermore, there are no data on this question from general practice, where the majority of DGBIs are diagnosed and managed. This study documents the proportion of childhood-diagnosed DGBIs that persisted into adulthood and what factors were associated with persistence. METHODS: General practice records were obtained for more than 60,000 patients whose medical record spanned both childhood and adulthood years. Patients with diagnosed organic gastrointestinal disorder were excluded. Medical records were also interrogated for potential risk factors. RESULTS: Eleven percent of patients with irritable bowel syndrome (IBS) and 20% of patients with functional dyspepsia (FD) diagnosed in childhood had repeat diagnoses of the same condition in adulthood. Female sex (odds ratio [OR] 2.02) was associated with persistence for IBS, while a childhood diagnosis of gastritis (OR 0.46) was risk-protective. Childhood non-steroidal anti-inflammatory drug use (OR 1.31, 95% confidence interval [CI] 1.09–1.56) was a risk factor for persistence in IBS. For FD, a childhood diagnosis of asthma (OR 1.30, 95% CI 1.00–1.70) was a risk factor, as was anxiety for both IBS (OR 1.24, 95% CI 1.00–1.54) and FD (OR 1.48 95% CI 1.11–1.97) with a similar finding for depression for IBS (OR 1.34, 95% CI 1.11–1.62) and FD (OR 1.88 95% CI 1.47–2.42). DISCUSSION: Childhood DGBIs persist into adulthood in 10%–20% of patients, suggesting that management monitoring should continue into adulthood. Those diagnosed with anxiety or mood disorders in childhood should receive particular attention, and prescription of non-steroidal anti-inflammatory drugs in children should be made judiciously.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (15)

nicole clemence roy

Professor

University of Otago

NEW ZEALAND
View details

Reuben Wong

Adj Associate Professor

National University of Singapore

SINGAPORE
View details

Michael Jones

Macquarie University

AUSTRALIA
View details

Alexander C. Ford

-

UNITED KINGDOM
View details

Ralf Kuja-Halkola

Karolinska Institutet

SWEDEN
View details

Warren McNabb

Professor of Nutritional Sciences

Massey University

NEW ZEALAND
View details

Awad I. Smew

Karolinska Institutet

SWEDEN
View details

Gerald Holtmann

-

AUSTRALIA
View details

Guy Eslick

Professor

Newcastle University

AUSTRALIA
View details

Lucas Wauters

-

BELGIUM
View details

Kevin Turner

University of Minnesota

UNITED STATES
View details

Anna Andreasson

Macquarie University

AUSTRALIA
View details

Peter Pockney

-

AUSTRALIA
View details

Michael Horowitz

University of Adelaide

AUSTRALIA
View details

Simon Keely

-

AUSTRALIA
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.